Impact of HER2-low and HER2-zero status on outcomes: A multicenter propensity-score matched study

被引：0
|
作者：
Cha, C. D. [1 ]
Kim, K. E. [2 ]
Kim, J. [3 ]
Um, E. [4 ]
Choi, N. [5 ]
Lee, J. [2 ]
Gwak, G. [3 ]
Kim, J. I. [4 ]
Chung, M. S. [1 ]
机构：
[1] Hanyang Univ, Coll Med, Surg, Seoul, South Korea
[2] Inje Univ, Coll Med, Surg, Haeundae Paik Hosp, Busan, South Korea
[3] Inje Univ, Sanggye Paik Hosp, Sch Med, Surg, Seoul, South Korea
[4] Inje Univ, Ilsan Paik Hosp, Ilsan, South Korea
[5] Hanyang Univ, Med Res Collaborating Ctr, Seoul, South Korea
来源：
BREAST | 2025年 / 80卷
关键词：
D O I：
10.1016/j.breast.2025.104089
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P248
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Prognostic stratification ability of the CPS plus EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy
    Roussot, Nicolas
    Constantin, Guillaume
    Desmoulins, Isabelle
    Bergeron, Anthony
    Arnould, Laurent
    Beltjens, Francoise
    Mayeur, Didier
    Kaderbhai, Coureche
    Hennequin, Audrey
    Jankowski, Clementine
    Padeano, Marie Martine
    Costaz, Helene
    Jacinto, Sarah
    Michel, Eloise
    Amet, Alix
    Coutant, Charles
    Costa, Brigitte
    Jouannaud, Christelle
    Deblock, Mathilde
    Levy, Christelle
    Ferrero, Jean -Marc.
    Kerbrat, Pierre
    Brain, Etienne
    Mouret-Reynier, Marie-Ange
    Coudert, Bruno
    Bertaut, Aurelie
    Ladoire, Sylvain
    EUROPEAN JOURNAL OF CANCER, 2024, 202
  • [42] Efficacy of first line CDK4/6 inhibitors in HER2-low vs HER2-zero, hormone receptor positive, HER2 negative metastatic breast cancer
    Sanchez-Bayona, Rodrigo
    Teran, Santiago
    De Torre, Ana Sanchez
    Alva, Manuel
    Lema, Laura
    Manso, Luis
    Toledo, Estefania
    Roncero, Ana Maria
    Merino, Cristina
    Martinez, Mario
    Parrilla, Lucia
    Ciruelos, Eva
    Tolosa, Pablo
    CANCER RESEARCH, 2022, 82 (04)
  • [43] The impact of HER2-low status on response to neoadjuvant chemotherapy in clinically HER2-negative breast cancer
    Wei Wang
    Tingting Zhu
    Hao Chen
    Yongzhong Yao
    Clinical and Translational Oncology, 2023, 25 : 1673 - 1681
  • [44] The impact of HER2-low status on response to neoadjuvant chemotherapy in clinically HER2-negative breast cancer
    Wang, Wei
    Zhu, Tingting
    Chen, Hao
    Yao, Yongzhong
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (06): : 1673 - 1681
  • [45] Editorial for "Development and Validation of a Deep Learning System to Differentiate HER2-Zero, HER2-Low, and HER2-Positive Breast Cancer Based on Dynamic Contrast-Enhanced MRI"
    Morrell, Glen R.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2025,
  • [46] The impact of the HER2-low status on conditional survival in patients with breast cancer
    Ma, Teng
    Liu, Changgen
    Ma, Tianyi
    Sun, Xinyi
    Cui, Jian
    Wang, Lulu
    Mao, Yan
    Wang, Haibo
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [47] Comparison of HER2-zero and HER2-low in terms of clinicopathological factors and survival in early-stage breast cancer: A systematic review and meta-analysis
    Ergun, Yakup
    Ucar, Gokhan
    Akagunduz, Baran
    CANCER TREATMENT REVIEWS, 2023, 115
  • [48] Preoperative Differentiation of HER2-Zero and HER2-Low from HER2-Positive Invasive Ductal Breast Cancers Using BI-RADS MRI Features and Machine Learning Modeling
    Zhou, Jiejie
    Zhang, Yang
    Miao, Haiwei
    Yoon, Ga Young
    Wang, Jinhao
    Lin, Yezhi
    Wang, Hailing
    Liu, Yan-Lin
    Chen, Jeon-Hor
    Pan, Zhifang
    Su, Min-Ying
    Wang, Meihao
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2025, 61 (02) : 928 - 941
  • [49] Clinical outcomes in early-stage TNBC according to HER2-low status
    Garrido-Castro, Ana
    Zakon, Danielle Brandes
    Jin, Qingchun
    Grimm, Michael
    Raghavendra, Akshara Singareeka
    Hughes, Melissa
    Cherian, Mathew
    Vincuilla, Julie
    Parker, Tonia
    Tarantino, Paolo
    Mittendorf, Elizabeth
    King, Tari
    Valero, Vicente
    Tripathy, Debu
    Ramaswamy, Bhuvaneswari
    Tolaney, Sara
    Tayob, Nabihah
    Lin, Nancy
    Stover, Daniel
    Barcenas, Carlos
    CANCER RESEARCH, 2024, 84 (09)
  • [50] Editorial for "Preoperative Differentiation of HER2-Zero and HER2-Low from HER2-Positive Invasive Ductal Breast Cancers Using BI-RADS MRI Features and Machine Learning Modeling"
    Bezerra, Thais Maria S.
    Bitencourt, Almir G. V.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2025, 61 (02) : 942 - 943
12345